PODD
NASDAQ
$163.72
Insulet Corporation (PODD)
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company is headquartered in Acton, Massachusetts.
Sector:
Healthcare
Industry:
Medical Devices
Buy
Target: $238.22 (+45.50%)
Market Cap
$11B
EPS 5Y CAGR
+50.11%
Revenue 5Y CAGR
+24.86%
Forward P/E
26.45
Price Chart
Valuation
Market Cap$11B
P/E47.27
Forward P/E26.45
PEG1.40
P/S3.80
P/B8.46
Profitability
Total Revenue (TTM)$2.90B
Gross Profit (TTM)$2.06B
EBITDA$602M
Profit Margin12%
Operating Margin16%
EPS$3.37
Financial Health
Debt-to-Equity1.4%
Free Cash Flow Yield3.73%
Growth & Risk
EPS 5Y CAGR+50.11%
Revenue 5Y CAGR+24.86%
Beta (5Y)0.66
Sharpe Ratio-1.22